| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Todd C. Davis | Director | $15.3M | Jul 2, 2025 | ||
| Ligand Pharmaceuticals Inc | Director, 10%+ Owner | $15M | Nov 6, 2025 | ||
| Motif Pharmaceuticals Ltd. | 10%+ Owner | $2.26M | Feb 15, 2024 | ||
| Boswell Prayer Ltd. | 10%+ Owner | $2.21M | Feb 15, 2024 | ||
| Aperture Healthcare Ventures Ltd. | 10%+ Owner | $2.05M | Feb 15, 2024 | ||
| AME Equities LLC | 10%+ Owner | $1.69M | Feb 15, 2024 | ||
| Ezra Friedberg | Director | $1.48M | Jul 2, 2025 | ||
| Richard Malamut | Director | $199K | Jul 2, 2025 | ||
| Francis Knuettel II | CFO, Treas & Secty | $114K | Jul 2, 2025 | ||
| Chia-Lin Simmons | Director | Apr 11, 2025 | |||
| Eric Lang | Chief Medical Officer | Jun 14, 2024 | |||
| Richard Baxter | Director | Jul 2, 2025 | |||
| Peter Greenleaf | Director | Jul 2, 2025 | |||
| Scott M. Plesha | CEO and President, Director | Jul 2, 2025 | |||
| Sai Rangarao | Chief Commercial Officer | Jul 2, 2025 | |||
| Matthew Pauls | Director | Jul 2, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|